CompletedNCT03418389
Evaluate and Monitor Physical Performance of Adults Treated With Asfotase Alfa for Hypophosphatasia
Studying Adult hypophosphatasia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Dr. Lothar Seefried
- Principal Investigator
- Lothar Seefried, MDWuerzburg University, Orthopedic Institute, Clinical Trial Unit
- Enrollment
- 23 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2018 – 2021
Study locations (1)
- Clinical Trial Unit, Orthopedic Department, Wuerzburg University, Würzburg, Germany
Collaborators
Alexion Pharmaceuticals, Inc.
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT03418389 on ClinicalTrials.govOther trials for Adult hypophosphatasia
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT07390240The Effect of Monoallelic Variants in the ALPL Gene on the Natural Course of Hypophosphatasia in RussiaAstraZeneca
- RECRUITINGNCT06574282Characteristics of Hypophosphatasia in Adult Patients in Rheumatology and Their Value in Developing an Algorithm to HPP-diagnosis - the COHIR Multi-center StudyUniversity of Bonn
- ACTIVE NOT RECRUITINGPHASE3NCT06079281Phase 3 Study of ALXN1850 Versus Placebo in Adolescent and Adult Participants With HPP Who Have Not Previously Been Treated With Asfotase AlfaAlexion Pharmaceuticals, Inc.
- RECRUITINGNCT05596539Prospective, Longitudinal, Observational Registry of Adult Patients With Hypophosphatasia (REG-HYPO)Assistance Publique - Hôpitaux de Paris
- RECRUITINGNCT02237625Natural History Study of Patients With Hypophosphatasia (HPP)Duke University